首页> 美国卫生研究院文献>other >Rare DMRT1 regulatory variants in severe spermatogenic failure
【2h】

Rare DMRT1 regulatory variants in severe spermatogenic failure

机译:严重生精功能衰竭的罕见DMRT1调节变体

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The DMRT1 (doublesex and mab-3 related transcription factor 1) gene has long been linked to sex-determining pathways across vertebrates and is known to play an essential role in gonadal development and maintenance of spermatogenesis in mice. In humans, the genomic region harboring the DMRT gene cluster has been implicated in disorders of sex development and recently DMRT1 deletions were shown to be associated with non-obstructive azoospermia (NOA). In this work we have employed different methods to screen a cohort of Portuguese NOA patients for DMRT1 exonic insertions and deletions (by MLPA; n=68) and point mutations (by Sanger sequencing; n=155). We have found three novel patient-specific non-coding variants in heterozygosity that were absent from 357 geographically matched controls. One of these is a complex variant with a putative regulatory role (c.-223_-219CGAAA>T), located in the promoter region within a conserved sequence involved in Dmrt1 repression. Moreover, while DMRT1 domains are highly conserved across vertebrates and show reduced levels of diversity in human populations, 2 rare synonymous substitutions (rs376518776 and rs34946058) and 2 rare non-coding variants that potentially affect DMRT1 expression and splicing (rs144122237 and rs200423545) were overrepresented in patients when compared to 376 Portuguese controls (301 fertile and 75 normozoospermic). Overall our previous and present results suggest a role of changes in DMRT1 dosage in NOA potentially also through a process of gene misregulation, even though DMRT1 deleterious variants seem to be rare.
机译:DMRT1(与doublesex和mab-3相关的转录因子1)基因长期以来与跨脊椎动物的性别决定途径相关,并且已知在性腺发育和小鼠精子形成的维持中起重要作用。在人类中,具有DMRT基因簇的基因组区域已牵涉性发育障碍,并且最近发现DMRT1缺失与非阻塞性无精子症(NOA)相关。在这项工作中,我们采用了不同的方法来筛选一组葡萄牙NOA患者的DMRT1外显子插入和缺失(通过MLPA; n = 68)和点突变(通过Sanger测序; n = 155)。我们发现杂合性中的三个新的患者特异性非编码变体,这在357个地理匹配的对照中不存在。其中之一是具有推定的调节作用的复杂变体(c.-223_-219CGAAA> T),其位于参与Dmrt1抑制的保守序列内的启动子区域。此外,虽然DMRT1域在整个脊椎动物中高度保守,并且在人类群体中显示出降低的多样性水平,但过分代表了2个罕见的同义替换(rs376518776和rs34946058)和2个可能影响DMRT1表达和剪接的罕见非编码变体(rs144122237和rs200423545)。与376名葡萄牙对照组(301名可育者和75名正常无精子症)相比。总的来说,我们以前和现在的结果表明,即使DMRT1有害变体似乎很少,但NORT中DMRT1剂量变化的潜在作用也可能是通过基因失调的过程。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号